IEC 60494-2
Railway Pantograph Head Type 2 Dimensions
This standard specifies dimensional and material requirements for Type 2 pantograph head contacts designed for metropolitan and urban railway systems with different electrical and mechanical demands than main line networks. It defines standardized contact strip profiles to ensure compatibility with metro and tram catenary systems and interoperability across urban transit networks. Manufacturers and transit operators require accreditation of this test to ensure product compliance and safe, reliable operation in metropolitan electrified rail systems. Standardized Type 2 heads reduce compatibility issues and maintenance costs across metro and tram networks.
What it measures
- Type 2 pantograph head contact width and profile geometry
- Carbon or composite strip material composition and thickness
- Contact surface hardness and wear resistance
- Electrical conductivity and contact resistance
- Mechanical deflection under typical operating forces
🇩🇪
DIN EN IEC 60494-1
🇬🇧
BS EN IEC 60494-1
🇫🇷
NF EN IEC 60494-1
🇮🇹
UNI EN IEC 60494-1
🇪🇸
UNE EN IEC 60494-1
🇳🇱
NEN EN IEC 60494-1
🇩🇪
DIN EN 50206-2
🇬🇧
BS EN 50206-2
🇫🇷
NF EN 50206-2
🇮🇹
UNI EN 50206-2
🇪🇸
UNE EN 50206-2
🇳🇱
NEN EN 50206-2
1,632
Accredited labs
19
Countries
Showing 701–725 of 875 labs
D-Dimere
Freies Protein-S Antigen
Protein S Antigen frei
vWV:Ag
Hemmkörper
+ 3 more
Basophile
Basophile absolut
Eosinophile
Eosinophile absolut
Erythrozyten
+ 3 more
Charakterisierung von akuten
Akuten Leukämien
B-Zellzahl (Immunstatus
manuelles Differentialblutbild
Zellzahlbestimmung
+ 3 more
Cardiolipin-Antikörper
Leptospiren-Antikörper
Shigellen (O-Antigene)
Treponema pallidum-Antikörper
Borrelien IgG + IgM
+ 3 more
anti-CMV IgG
anti-CMV IgM
CMV IgG Avidität
Chikungunya Virus IgG
Chikungunya Virus IgM
+ 3 more
HLA-Antikörpertestung (Detektion)
HLA-Antikörpertestung
(Spezifizierung Klasse I und
(Spezifizierung
komplementbindender Antikörper
+ 3 more
NGS-Panel-Analyse (SNVs, Indels
CNVs), Gene:
WDR73, WNT4, WNT5A, XRCC4, YY1, ZMPSTE24
PYCR1, RNF213, ROBO4, SETD5, SLC2A10, SL
GPC3, HERC1, HIST1H1E, NFIX, OFD1, RNF13
+ 3 more
RPL27, RPL3, RPL31, RPL34, RPL35, RPL35A
Diamond-Blackfan-Anämie ; DBA
NOP10, PARN, RPA1, RTEL1, SAMD9, SAMD9L,
Dyskeratosis congenita; DC Panel
NOP10, PARN, POT1, RPA1, RTEL1, SAMD9, S
+ 3 more
Urinstatus
Leukozyten
Neutrophile Granulozyten
Eosinophyle Granulozyten
Basophile Granulozyten
+ 3 more
Differenzierung peripheres
Erstellung eines Differentialblutbilds
Differenzierung Knochenmark
Pappenheim-Färbung
Peroxidase-Reaktion
+ 3 more
Universitätsklinikum Freiburg MVZ des Universitätsklinikums Freiburg, Bereich Transfusionsmedizin
Active
HLA-Antikörpertestung (Detektion)
HLA-Antikörpertestung
(Spezifizierung Klasse I und
(Spezifizierung
komplementbindender Antikörper
+ 3 more
Anaerobier-Resistenz
Bakterien-Resistenz
Hefen-Resistenz
Carbapenemasenachweis
Cryptosporidien, Giardia
+ 3 more
Thrombozyten
Zellzählung und -differenzierung
Calcium, ionisiert
Natriumchlorid
Glukose
+ 3 more
DPYD-Genotypisierung vor 5 FU
Therapie, SNV
Polyposissyndrome (APC, BMPR1A, MUTYH, N
(Custom made by TWIST), SNV
Hereditärer Darmkrebs inklusive
+ 3 more
Thrombozytenaggregation
Arachidonsäure
Kollagen/Epinephrin
Ristocetin
Erythrozyten
+ 3 more
9-OH-Risperidon/Paliperidon
Aripiprazol
Citalopram
Clozapin, Norclozapin
Cyclosporin (CSA)
+ 3 more
Borrelia burgdorferi
Chlamydophila pneumoniae
Coxiella burnetii
Toxoplasma gondii
Adenovirus
+ 3 more
Syndrom, Gene: AKT1, PIK3CA,
PTEN, SEC23B
Carney-Komplex, Gene: PRKAR1A,
OMIM*600993, STK11
Cowden-Syndrom, Gene: AKT1,
+ 3 more
Blutgruppe AB0
Rh-Faktor
Rh-Formel
Kell-Ag
A-Untergruppe
+ 3 more
Toxoplasmen-IgG
Treponema pallidum-IgG
anti-HBc AK
anti-HBs AK
anti-CMV IgG
+ 3 more
DPYD (SNP-Analyse)
JAK2 Kodon 617 Mutationsanalyse
T-Zellklonalitätsanalyse (TCRG und
TCRB)
B-Zellklonalitätsanalyse (IGH, IGL, IGK)
+ 3 more
Aminosäuren
Second Tier Test IVA Screening
(C5 -Carnitin Isobaren)
17-α-OH-Progesteron (17-OH-P)
Biotinidase
+ 3 more
5-Fluorouracil-Toxizität (DPYD)
Cowden-Syndrom (PTEN)
Diffuses Magenkarzinom (CDH1)
Hereditärer Brust- und
Eierstockkrebs (HBOC), (BRCA1, BRCA2, CH
+ 3 more
Factor)
Treponema pallidum-Antikörper
Treponema pallidum (TPHA)
Treponema pallidium (VDRL)
Escherichia coli Serotyp
+ 3 more
Cyclosporin A
Everolimus
FK 506 (Tacrolimus)
Sirolimus
6-Methylmercaptopurin
+ 3 more
No matching labs found.